文献速递肾小球疾病慢性肾脏病

IgA肾病患者炎症性肠病更常见且预示ESKD进展:瑞典人群队列研究

Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
PubMed 文献 · J Am Soc Nephrol · 2020-11-11

该瑞典人群队列研究比较了3963例活检证实的IgA肾病患者与19978例匹配对照,随访至2015年。IgA肾病患者炎症性肠病风险显著增加(调整HR 3.29),且诊断前炎症性肠病也更常见(OR 2.37)。合并炎症性肠病与IgA肾病患者进展至ESKD风险升高相关(HR 1.84)。

要点

  • IgA肾病患者炎症性肠病风险约为对照的3倍。
  • IgA肾病诊断前炎症性肠病也更常见。
  • 合并炎症性肠病增加IgA肾病进展至ESKD风险。

核心结论

  • IgA肾病患者在肾病诊断前后炎症性肠病风险均增加。
  • 合并炎症性肠病升高IgA肾病患者进展至ESKD的风险。

研究设计与样本

  • 瑞典人群为基础队列研究,纳入3963例活检证实的IgA肾病患者与19978例匹配对照。
  • 1974至2011年纳入,随访至2015年,使用Cox回归和条件logistic回归分析。

主要发现

  • 中位随访12.6年,IgA肾病组196例(4.95%)发生炎症性肠病,对照组330例(1.65%),调整HR 3.29(95%CI 2.73-3.96)。
  • IgA肾病诊断前炎症性肠病更常见:103例(2.53%) vs 220例(1.09%),OR 2.37(95%CI 1.87-3.01)。
  • 炎症性肠病与ESKD风险增加相关:logistic回归OR 2.60(95%CI 2.02-3.35),时变Cox回归HR 1.84(95%CI 1.33-2.55)。

临床怎么用

  • 对IgA肾病患者应关注炎症性肠病症状并考虑筛查。
  • 合并炎症性肠病的IgA肾病患者需警惕ESKD进展风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Case reports suggest an association between inflammatory bowel disease, a chronic autoimmune condition linked to increased circulating IgA levels, and IgA nephropathy, the most common form of primary GN and a leading cause of ESKD. METHODS: In a Swedish population-based cohort study, we compared 3963 biopsy-verified IgA nephropathy patients with 19,978 matched controls between 1974 and 2011, following up participants until 2015. Inflammatory bowel disease data and ESKD status were obtained through national medical registers. We applied Cox regression to estimate hazard ratios (HRs) for future inflammatory bowel disease in IgA nephropathy and conditional logistic regression to assess risk of earlier inflammatory bowel disease in IgA nephropathy. We also explored whether inflammatory bowel disease affects development of ESKD in IgA nephropathy. RESULTS: During a median follow-up of 12.6 years, 196 (4.95%) patients with IgA nephropathy and 330 (1.65%) matched controls developed inflammatory bowel disease (adjusted HR, 3.29; 95% confidence interval [95% CI], 2.73 to 3.96). Inflammatory bowel disease also was more common before a confirmed IgA nephropathy diagnosis. Some 103 (2.53%) IgA nephropathy patients had an earlier inflammatory bowel disease diagnosis compared with 220 (1.09%) controls (odds ratio [OR], 2.37; 95% CI, 1.87 to 3.01). Both logistic regression (OR, 2.60; 95% CI, 2.02 to 3.35) and time-varying Cox regression (HR, 1.84; 95% CI, 1.33 to 2.55) demonstrated that inflammatory bowel disease was associated with increased ESKD risk in patients with IgA nephropathy. CONCLUSIONS: Patients with IgA nephropathy have an increased risk of inflammatory bowel disease both before and after their nephropathy diagnosis. In addition, among patients with IgA nephropathy, comorbid inflammatory bowel disease elevates the risk of progression to ESKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Rehnberg J, Symreng A, Ludvigsson JF, et al. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study. J Am Soc Nephrol. 2020. PMID: 33177116. doi:10.1681/ASN.2020060848

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。